2242616-04-0
Chemical Structure
Raphin1 acetate
- CAS No.: 2242616-04-0
- Formula:C10H12Cl2N4O2
- Molecular Weight:291.13
IUPAC Name: (E)-2-(2,3-dichlorobenzylidene)hydrazine-1-carboximidamide acetate
InChIKey: WSDLUFBVKWLRSN-GAYQJXMFSA-N
SMILES: N=C(N/N=C/C1=CC=CC(Cl)=C1Cl)N.CC(O)=O
Biological Activity: Raphin1 acetate is an orally bioavailable, selective inhibitor of the regulatory phosphatase PPP1R15B (R15B). Raphin1 acetate binds strongly to the R15B-PP1c holophosphatase (Kd=33 nM), and shows ~30-fold selective in binding R15B-PP1c over R15A-PP1c. Raphin1 acetate crosses the blood-brain barrier, and reduces organismal and molecular deficits in a mouse model of a protein misfolding disease[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Raphin1 acetate | 99.93% | Raphin1 acetate is an orally bioavailable, selective inhibitor of the regulatory phosphatase PPP1R15B (R15B). Raphin1 acetate binds strongly to the R15B-PP1c holophosphatase (Kd=33 nM), and shows ~30-fold selective in binding R15B-PP1c over R15A-PP1c. Raphin1 acetate crosses the blood-brain barrier, and reduces organismal and molecular deficits in a mouse model of a protein misfolding disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
